iREACH: 2021-2022 Flu Season Talking Points
This talking points document was developed by iREACH Subject Matter Experts to provide information and resources for the 2021-2022 flu season.
This talking points document was developed by iREACH Subject Matter Experts to provide information and resources for the 2021-2022 flu season.
The three chapters of this resource guide provide insight into how to do this. You can download a PDF of the whole guide, or each individual chapter.
Chapter 3 of the Resource Guide offers effective approaches to educating the public and policymakers, including developing outreach plans, tips for successful meetings with policymakers, and more.
Chapter 1 of the Resource Guide highlights the differences between education, advocacy, and lobbying, and helps IPs understand what is allowable with different funding sources. It also features “Key Dates in the Annual Congressional Appropriations Process,” which helps illustrate the Congressional calendar.
Chapter 2 of the Resource Guide discusses the key players that shape the immunization policy landscape in your state, highlights the benefits of partnering with them, and offers suggestions for building effective relationships.
This presentation offers key information on how Medicaid and immunization programs work together.
AIM conducted a survey of members to explore the role of public health clinics (excluding FQHCs, RHCs, and public health clinics which are deputized as FQHCs or RHCs) in vaccinating underinsured and the number of underinsured children served by those…
This talking points document was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide information on the difference between vaccines that have been authorized by the FDA vs. approved by the FDA.
Learn important steps in identifying and engaging with communities at risk for vaccine-preventable diseases in culturally competent ways to manage vaccine hesitancy, particularly during outbreaks.
Chapter 1 of the Vaccine Confidence Resource Guide highlights IP experiences, lessons learned, and resources to help IPs minimize the impact of vocal vaccine opposition during legislative and rulemaking processes and maximize efforts to inform policymakers of the value of immunization.